Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer

CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) have emerged as a dominant T cell population inhibiting anti-tumor effector T cells. Initial strategies used for Treg-depletion (cyclophosphamide, anti-CD25 mAb…) also targeted activated T cells, as they share many phenotypic markers. Current, ameliora...

詳細記述

保存先:
書誌詳細
主要な著者: Pere, Helene, Tanchot, Corinne, Bayry, Jagadeesh, Terme, Magali, Taieb, Julien, Badoual, Cecile, Adotevi, Olivier, Merillon, Nathalie, Marcheteau, Elie, Quillien, Ve´ronique, Banissi, Claire, Carpentier, Alain, Sandoval, Federico, Nizard, Mevyn, Quintin-Colonna, Françoise, Kroemer, Guido, Fridman, Wolf H., Zitvogel, Laurence, Oudard, Ste´phane, Tartour, Eric
フォーマット: Artigo
言語:Inglês
出版事項: Landes Bioscience 2012
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3382865/
https://ncbi.nlm.nih.gov/pubmed/22737608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.18852
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料